𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cisplatin and 5-fluorouracil chemotherapy in advanced of recurrent squamous cell carcinoma of the head and neck

✍ Scribed by Sacks, H.G.

Book ID
122515237
Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
155 KB
Volume
46
Category
Article
ISSN
1531-5053

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cisplatin-5-fluorouracil chemotherapy fo
Cisplatin-5-fluorouracil chemotherapy for advanced inoperable squamous carcinoma of the head and neck
✍ Johnson, Jonas T. ;Mayernik, David G. ;Myers, Eugene N. ;Nolan, Teresa A. ;Schra πŸ“‚ Article πŸ“… 1987 πŸ› Wiley (John Wiley & Sons) βš– 368 KB πŸ‘ 2 views

Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt

Paclitaxel, cisplatin, and 5-fluorouraci
Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck
✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi

Pilot study of intraoperative chemothera
Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck
✍ Ozlem E. Tulunay; Ileana I. Enamorado; Omer Kucuk; Lance K. Heilbrun; Jose E. Ot πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 3 views

## Abstract ## Background. Intraoperative manipulation of the tumor during cancer surgery has long been recognized as a source of metastasis and contamination of the surgical wound during tumor removal. We explored the use of intraoperative chemotherapy to minimize the risk of tumor cell implantat